LSV Asset Management
REGN icon

LSV Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

LSV Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$158M Buy
253,200
+56,921
+29% +$38.7M 0.29% 112
2026
Q1 		$152M Buy
196,279
+29,765
+18% +$22.8M 0.33% 96
2025
Q4 		$129M Buy
166,514
+110,914
+199% +$75.3M 0.28% 112
2025
Q3 		$31.3M Buy
+55,600
New +$31.4M 0.07% 259
2025
Q2 		– Sell
-8
Closed -$5K – 857
2025
Q1 		$5K Buy
8
+4
+100% +$2.75K ﹤0.01% 829
2024
Q4 		$3K Buy
+4
New +$3.36K ﹤0.01% 823
2023
Q2 		– Sell
-49,400
Closed -$40.6M – 920
2023
Q1 		$40.6M Sell
49,400
-2,700
-5% -$2.04M 0.09% 226
2022
Q4 		$37.6M Sell
52,100
-1,700
-3% -$1.25M 0.08% 230
2022
Q3 		$37.1M Sell
53,800
-3,600
-6% -$2.27M 0.09% 231
2022
Q2 		$33.9M Sell
57,400
-134,330
-70% -$87.3M 0.07% 246
2022
Q1 		$134M Sell
191,730
-8,527
-4% -$5.39M 0.25% 128
2021
Q4 		$126M Sell
200,257
-9,610
-5% -$5.91M 0.22% 138
2021
Q3 		$127M Sell
209,867
-26,520
-11% -$16.5M 0.23% 130
2021
Q2 		$132M Sell
236,387
-15,564
-6% -$7.89M 0.22% 141
2021
Q1 		$119M Sell
251,951
-11,731
-4% -$5.71M 0.2% 150
2020
Q4 		$127M Sell
263,682
-34,930
-12% -$18.9M 0.23% 130
2020
Q3 		$167M Sell
298,612
-23,024
-7% -$14M 0.34% 92
2020
Q2 		$201M Sell
321,636
-63,502
-16% -$36M 0.42% 63
2020
Q1 		$188M Buy
385,138
+83,818
+28% +$34.6M 0.45% 53
2019
Q4 		$113M Buy
301,320
+275,290
+1,058% +$92.6M 0.18% 153
2019
Q3 		$7.22M Buy
+26,030
New +$7.7M 0.01% 500

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

LSV Asset Management's REGN Position: Q2 2026 in Review

LSV Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 29% in Q2 2026, buying an estimated $38.7M and bringing the position to 253,200 shares worth $158M. The position accounts for 0.29% of the portfolio, ranked #112.

LSV Asset Management first reported a position in REGN in Q3 2019 and has held it in 21 quarters since. The position peaked at $201M in Q2 2020. 760 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • LSV Asset Management held 253,200 shares of Regeneron Pharmaceuticals worth $158M as of Q2 2026.
  • LSV Asset Management bought 56,921 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $38.7M.
  • Regeneron Pharmaceuticals made up 0.29% of LSV Asset Management's portfolio in Q2 2026, its #112 holding.
  • LSV Asset Management first reported a position in Regeneron Pharmaceuticals in Q3 2019 and has held it in 21 quarters since.
  • LSV Asset Management's Regeneron Pharmaceuticals position peaked at $201M in Q2 2020.
  • 760 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on LSV Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.